bcl-2+ indicates abnormal overexpression of oncogenes, which generally indicates tumor generation, metastasis, and spread. bcl-2 is a B lymphoblastoma-2 gene, i.e., an inhibitor of apoptosis and a gene that plays an important role in tumorigenesis by preventing apoptosis, and generally the process of apoptosis has an induction phase, an effector phase, and a degradation phase. bcl-2+ indicates high expression of B lymphoblastoma-2 gene, i.e. abnormal expression of oncogenes, and also indicates the occurrence of tumor generation, metastasis, and even proliferation. Clinically, this item can be beneficial to the understanding of cancer lesions and cancer awareness, thus helpful to the treatment of the disease; it is recommended that patients should consult the doctor in time, and should not be negligent so as not to delay the condition.